Latest publications

Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry. Ariëns LF, Van der Schaft J, Bakker DS, Balak D, Romeijn ML, Kouwenhoven T et al. Allergy 2019 Oct 08

The Patient-reported Disease Burden in Adults with Atopic Dermatitis: A Cross-sectional Study in Europe and Canada. De Bruin-Weller M, Gadkari A, Auziere S, Simpson EL, Puig L, Barbarot S et al. J Eur Acad Dermatol Venereol 2019 Oct 06

3-year follow-up after peanut food challenges: accidental reactions in allergic children and introduction failure in tolerant children. Kansen HM, Le TM, Knulst AC, Gorissen DMW, Van der Ent CK, Meijer Y et al. J. Allergy Clin. Immunol. 2019 Sep 27

Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment. Bakker DS, Drylewicz J, Nierkens S, Knol EF, Giovannone B, Delemarre EM et al. Clin. Exp. Allergy 2019 Sep 13

Ara h 7 isoforms share many linear epitopes: Are 3D epitopes crucial to elucidate divergent abilities? Ehlers AM, Klinge M, Suer W, Weimann Y, Knulst AC, Besa F et al. Clin. Exp. Allergy 2019 Sep 13

ASO Author Reflections: Sentinel Lymph Node Biopsy Trend in Melanoma: The More the Merrier. El Sharouni MA, Witkamp A, Sigurdsson V, Van Diest PJ et al. Ann. Surg. Oncol. 2019 Sep 05

Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab-related conjunctivitis. Voorberg AN, Den Dunnen WFA, Wijdh RHJ, De Bruin-Weller MS, Schuttelaar MLA et al. J Eur Acad Dermatol Venereol 2019 Aug 29

Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study. Deleuran M, Thaçi D, Beck LA, De Bruin-Weller M, Blauvelt A, Forman S et al. J. Am. Acad. Dermatol. 2019 Jul 30

High occurrence of antihistamine resistance in patients with recurrent idiopathic angioedema. Hofman ZLM, Van West N, Hack CE, Knulst AC, Maas C, Röckmann H et al. Clin Transl Allergy 2019; 9:35

Intra-nodal nevi in sentinel node-negative patients with cutaneous melanoma does not influence survival. De Beer FSA, Van Diest PJ, Sigurdsson V, El Sharouni M et al. J Eur Acad Dermatol Venereol 2019 Jul 18

Sesame oleosins are minor allergens. Ehlers AM, Rossnagel M, Brix B, Blankestijn MA, Le TM, Suer W et al. Clin Transl Allergy 2019; 9:32

Time to get rid of the Investigator's Global Assessment as the primary outcome for clinical trials in atopic dermatitis? De Bruin-Weller M et al. Br. J. Dermatol. 2019 Jul; 181(1):12-13

Sex matters: men with melanoma have a worse prognosis than women. El Sharouni MA, Witkamp AJ, Sigurdsson V, Van Diest PJ, Louwman MWJ, Kukutsch NA et al. J Eur Acad Dermatol Venereol 2019 Jun 27

Comparison of Survival Between Patients With Single vs Multiple Primary Cutaneous Melanomas. El Sharouni MA, Witkamp AJ, Sigurdsson V, Van Diest PJ et al. JAMA Dermatol 2019 Jun 26

European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period. Vestergaard C, Wollenberg A, Barbarot S, Christen-Zaech S, Deleuran M, Spuls P et al. J Eur Acad Dermatol Venereol 2019 Sep; 33(9):1644-1659